Prefer Glenmark Pharma, Sun Pharmaceutical, Lupin: Sharmila Joshi

Sharmila Joshi of sharmilajoshi.com told CNBC-TV18, "I had a buy on Marksans Pharma, but the buy was at a much higher price and that was probably at the fag end of that last pharma rally and since then the stock has only corrected."

"Given the kind of correction that we have seen across stocks in pharmaceutical space, use this as an opportunity to shift. So shift to a stock where perhaps the fundamentals are a lot better and you can hope to make money from current levels. So I would recommend a Glenmark Pharma, Sun Pharmaceutical, or Lupin at this price over a Marksan Pharma," she added.